Optiscan Imaging Stock

Optiscan Imaging R&D per Employee

The R&D Spending per Employee of Optiscan Imaging (OIL.AX) as of Aug 4, 2026 is 636,650.00 AUD. In the previous year, R&D Spending per Employee was 487,650.00 AUD — a change of 30.55% (higher).

R&D per Employee

636,650.00AUD

YoY

30.55%

Last updated:

R&D Spending per Employee of Optiscan Imaging is 2026 636,650.00 AUD. R&D Spending per Employee of Optiscan Imaging was 2025 487,650.00 AUD. It decreases by 30.55% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

R&D Spending per Employee of Optiscan Imaging is 636,650.00 AUD in 2026.

R&D Spending per Employee of Optiscan Imaging changed from 487,650.00 AUD to 636,650.00 AUD, representing a 30.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Optiscan Imaging historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Optiscan Imaging

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Optiscan Imaging